Furthermore, activation of the NLRP3 inflammasome by cholesterol crystal deposition within plaques exacerbates inflammation and thrombogenic risk [36]
The Guardian also reported on Phase 3 trial results showing substantial average weight loss among adults with obesity or overweight, while noting common gastrointestinal side effects such as nausea, vomiting, diarrhea, and constipation
It is also approved to reduce the risk of major cardiovascular events (like heart attack or stroke) in adults with type 2 diabetes and established cardiovascular disease
The Ca 2+ influx through the NMDA receptor appears to be one of the keys to producing neuronal damage since specifically blocking activation of this receptor attenuates some of the neuronal injury following stroke
When compared with Naltrexone/Bupropion, Tirzepatide users show lower rates of cataracts (HR 0.46, 95% CI 0.230.92, p = 0.025) and oculomotor dysfunction (HR 0.31, 95% CI 0.160.60, p = 2.3 10 4 )